|
CA2604363C
(en)
|
2005-04-08 |
2015-06-16 |
Wyeth |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US20070184072A1
(en)
|
2005-04-08 |
2007-08-09 |
Wyeth |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US7955605B2
(en)
*
|
2005-04-08 |
2011-06-07 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US7709001B2
(en)
*
|
2005-04-08 |
2010-05-04 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
|
WO2007127668A2
(en)
*
|
2006-04-26 |
2007-11-08 |
Wyeth |
Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
|
|
US8808707B1
(en)
|
2006-05-08 |
2014-08-19 |
Wyeth Llc |
Pneumococcal dosing regimen
|
|
PT2129693T
(pt)
*
|
2007-03-23 |
2017-02-14 |
Wyeth Llc |
Processo de purificação abreviado para a produção de polissacáridos capsulares de streptococcus pneumoniae
|
|
WO2009111588A1
(en)
*
|
2008-03-04 |
2009-09-11 |
Liquidia Technologies, Inc. |
Immunomodulator particles and methods of treating
|
|
CN103816870B
(zh)
*
|
2008-12-03 |
2016-11-23 |
株式会社钟化 |
含有甲酰基的多孔性载体、使用该多孔性载体的吸附体以及它们的制造方法
|
|
GB0822634D0
(en)
|
2008-12-11 |
2009-01-21 |
Novartis Ag |
Meningitis vaccines
|
|
ES2749952T3
(es)
*
|
2008-12-18 |
2020-03-24 |
Wyeth Llc |
Procedimiento de control del peso molecular de polisacáridos de Streptococcus pneumoniae usando carbono
|
|
KR20110091546A
(ko)
*
|
2008-12-18 |
2011-08-11 |
와이어쓰 엘엘씨 |
스트렙토코커스 뉴모니에 혈청형 19ａ 폴리사카라이드 분자량을 조절하는 방법
|
|
EP3017826A1
(en)
|
2009-03-24 |
2016-05-11 |
Novartis AG |
Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
|
|
HUE049695T2
(hu)
|
2009-03-24 |
2020-10-28 |
Glaxosmithkline Biologicals Sa |
Adjuváló H meningococcus faktort kötõ fehérje
|
|
AU2010243285B2
(en)
|
2009-04-30 |
2013-06-06 |
Coley Pharmaceutical Group, Inc. |
Pneumococcal vaccine and uses thereof
|
|
US9649372B2
(en)
|
2009-12-22 |
2017-05-16 |
Sanofi Pasteur Limited |
Immunogenic compositions and related methods
|
|
CN102834112B
(zh)
*
|
2010-02-22 |
2016-02-24 |
流体科技公司 |
多糖颗粒疫苗
|
|
CN101785857B
(zh)
*
|
2010-03-05 |
2012-09-26 |
成都安特金生物技术有限公司 |
一种新的肺炎球菌结合疫苗及其制备方法
|
|
AU2011258165B2
(en)
|
2010-05-26 |
2016-11-17 |
Selecta Biosciences, Inc. |
Dose selection of adjuvanted synthetic nanocarriers
|
|
PT2575870T
(pt)
|
2010-06-04 |
2017-02-10 |
Wyeth Llc |
Formulações de vacinas
|
|
CA2803239A1
(en)
|
2010-06-25 |
2011-12-29 |
Novartis Ag |
Combinations of meningococcal factor h binding proteins
|
|
CN102462839B
(zh)
*
|
2010-11-12 |
2016-03-30 |
北京生物制品研究所 |
多糖结合疫苗及其制备方法
|
|
WO2012117377A1
(en)
|
2011-03-02 |
2012-09-07 |
Novartis Ag |
Combination vaccines with lower doses of antigen and/or adjuvant
|
|
JP2014521687A
(ja)
|
2011-07-29 |
2014-08-28 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
体液性および細胞傷害性ｔリンパ球（ｃｔｌ）免疫応答を生成する合成ナノキャリア
|
|
KR101315599B1
(ko)
|
2011-10-25 |
2013-10-10 |
건국대학교 산학협력단 |
폐렴균점막다당질 유형14 （ｃｐｓ１４）와 호스래디시 퍼옥시다제의 당단백중합체
|
|
EP2797624A1
(en)
|
2011-12-29 |
2014-11-05 |
Novartis AG |
Adjuvanted combinations of meningococcal factor h binding proteins
|
|
JP2015510872A
(ja)
|
2012-03-07 |
2015-04-13 |
ノバルティス アーゲー |
Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ抗原の増強された製剤
|
|
CN104159603A
(zh)
|
2012-03-08 |
2014-11-19 |
诺华股份有限公司 |
带有tlr4激动剂的联合疫苗
|
|
KR102057217B1
(ko)
|
2012-06-20 |
2020-01-22 |
에스케이바이오사이언스 주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
US9526776B2
(en)
|
2012-09-06 |
2016-12-27 |
Glaxosmithkline Biologicals Sa |
Combination vaccines with serogroup B meningococcus and D/T/P
|
|
BR112015005081B1
(pt)
*
|
2012-09-07 |
2021-10-26 |
Sk Bioscience Co., Ltd. |
Método para produzir um polissacarídeo capsular tendo um sorotipo de pneumococo
|
|
KR20140075196A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
EP2934574A1
(en)
|
2012-12-18 |
2015-10-28 |
GlaxoSmithKline Biologicals SA |
Conjugates for protecting against diphtheria and/or tetanus
|
|
EP3363806B1
(en)
|
2012-12-20 |
2022-11-16 |
Pfizer Inc. |
Glycoconjugation process
|
|
BR112015029051A2
(pt)
*
|
2013-05-20 |
2017-07-25 |
Shantha Biotechnics Private Ltd |
processos para a purificação de um conjugado de proteínas de polissacarídeos e para a fabricação de uma vacina
|
|
WO2015073831A1
(en)
*
|
2013-11-15 |
2015-05-21 |
Liquidia Technologies, Inc. |
Virtual conjugate particles
|
|
CN120718167A
(zh)
|
2014-01-21 |
2025-09-30 |
辉瑞大药厂 |
肺炎链球菌荚膜多糖及其缀合物
|
|
IL312327B2
(en)
|
2014-01-21 |
2026-02-01 |
Pfizer |
Immunogenic preparations comprising conjugated capsular saccharide antigens and their uses
|
|
US11160855B2
(en)
|
2014-01-21 |
2021-11-02 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
BR112016016580B1
(pt)
|
2014-01-21 |
2024-01-09 |
Pfizer Inc |
Processo para a preparação de um conjugado imunogênico, conjugado imunogênico, composição imunogênica, e vacina
|
|
CN104069504B
(zh)
|
2014-05-11 |
2019-09-24 |
江苏康泰生物医学技术有限公司 |
一种增强多糖蛋白结合物免疫原性的方法
|
|
EP2987408A1
(en)
*
|
2014-08-20 |
2016-02-24 |
National University of Ireland, Galway |
Iodophor composition with improved stability in the presence of organic material
|
|
CN107427568B
(zh)
|
2015-01-15 |
2021-12-14 |
辉瑞公司 |
用于肺炎球菌疫苗中的免疫原性组合物
|
|
PE20220774A1
(es)
|
2015-05-04 |
2022-05-16 |
Pfizer |
Conjugados proteina-polisacarido de estreptococo grupo b, metodos para producir conjugados, composiciones inmunogenas que comprenden conjugados y sus usos
|
|
WO2016207905A2
(en)
*
|
2015-06-23 |
2016-12-29 |
Biological E Limited |
Multivalent pneumococcal conjugate vaccine
|
|
CN106109486A
(zh)
*
|
2015-07-06 |
2016-11-16 |
北京科兴中维生物技术有限公司 |
一种组合物及其制备方法与应用
|
|
CN108367063A
(zh)
|
2015-07-21 |
2018-08-03 |
辉瑞公司 |
包含缀合的荚膜糖抗原的免疫原性组合物及其试剂盒和用途
|
|
US20180271969A1
(en)
|
2015-10-07 |
2018-09-27 |
Boehringer Ingelheim Vetmedica, Inc. |
Streptococcus suis polysaccharide-protein conjugate composition
|
|
JP6884145B2
(ja)
|
2015-11-20 |
2021-06-09 |
ファイザー・インク |
肺炎連鎖球菌ワクチンにおいて用いるための免疫原性組成物
|
|
EP4488286A3
(en)
*
|
2016-03-31 |
2025-04-02 |
Pogona, Llc |
Saccharide-polypeptide conjugate compositions and methods of use thereof
|
|
JP7001686B2
(ja)
|
2016-08-05 |
2022-02-04 |
サノフィ パスツール インコーポレイティッド |
多価肺炎球菌多糖体－タンパク質コンジュゲート組成物
|
|
KR102437120B1
(ko)
|
2016-08-05 |
2022-08-25 |
사노피 파스퇴르 인코포레이티드 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
BR112019006278A2
(pt)
|
2016-09-30 |
2019-07-02 |
Biological E Limited |
composições de vacina pneumocócica multivalente que compreendem conjugados de polissacarídeo-proteína
|
|
WO2018080213A1
(ko)
*
|
2016-10-28 |
2018-05-03 |
주식회사 엘지화학 |
향상된 IgG 역가를 갖는 다가면역원성 조성물 및 이의 용도
|
|
US10751402B2
(en)
|
2016-11-09 |
2020-08-25 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
|
ES3024474T3
(en)
|
2016-12-30 |
2025-06-04 |
Vaxcyte Inc |
Polypeptide-antigen conjugates with non-natural amino acids
|
|
US11413344B2
(en)
|
2017-01-20 |
2022-08-16 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
|
CN110225764A
(zh)
*
|
2017-01-31 |
2019-09-10 |
默沙东公司 |
制备多糖-蛋白缀合物的方法
|
|
WO2018144799A1
(en)
|
2017-02-03 |
2018-08-09 |
SCHADECK, Eva, Barbara |
Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
|
|
US11400162B2
(en)
*
|
2017-02-24 |
2022-08-02 |
Merck Sharp & Dohme Llc |
Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein
|
|
CA3050120A1
(en)
|
2017-02-24 |
2018-08-30 |
Merck Sharp & Dohme Corp. |
Enhancing immunogenicity of streptococcus pneumoniae polysaccharide-protein conjugates
|
|
US10729763B2
(en)
|
2017-06-10 |
2020-08-04 |
Inventprise, Llc |
Mixtures of polysaccharide-protein pegylated compounds
|
|
MX2019014829A
(es)
|
2017-06-10 |
2020-08-17 |
Inventprise Llc |
Vacunas de conjugado multivalente con polisacáridos de conjugado bivalente o multivalente que proporcionan inmunogenicidad y avidez mejoradas.
|
|
WO2019043245A1
(en)
*
|
2017-09-04 |
2019-03-07 |
London School Of Hygiene And Tropical Medicine |
MICROBIAL CELLS EXPRESSING STREPTOCOCCAL SERROTYPES
|
|
PT3678654T
(pt)
|
2017-09-07 |
2024-08-05 |
Merck Sharp & Dohme Llc |
Polissacáridos pneumocócicos e sua utilização em conjugados imunogénicos de polissacárido-proteína transportadora
|
|
CN111065387B
(zh)
|
2017-09-07 |
2023-08-25 |
默沙东有限责任公司 |
肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
|
|
WO2019050813A1
(en)
|
2017-09-07 |
2019-03-14 |
Merck Sharp & Dohme Corp. |
ANTI-PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC CONJUGATES POLYSACCHARIDE-PROTEIN CARRIER
|
|
AU2018328040B2
(en)
*
|
2017-09-07 |
2025-01-16 |
Merck Sharp & Dohme Llc |
Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein
|
|
US12257295B2
(en)
|
2017-10-04 |
2025-03-25 |
Pogona, LLC |
Saccharide-polypeptide conjugate compositions and methods of use thereof
|
|
TWI725359B
(zh)
|
2017-12-06 |
2021-04-21 |
美商默沙東藥廠 |
包含肺炎鏈球菌多醣-蛋白結合物之組合物及其使用方法
|
|
KR20230008923A
(ko)
|
2018-02-05 |
2023-01-16 |
사노피 파스퇴르 인코포레이티드 |
다가 폐렴구균성 다당류-단백질 접합체 조성물
|
|
AU2019215212B2
(en)
|
2018-02-05 |
2025-05-15 |
Sk Bioscience Co., Ltd. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
JP2021522213A
(ja)
|
2018-04-18 |
2021-08-30 |
エスケー バイオサイエンス カンパニー リミテッド |
ストレプトコッカス・ニューモニエ莢膜多糖類及びその免疫原性接合体
|
|
EP3787673A4
(en)
*
|
2018-04-30 |
2022-04-27 |
Merck Sharp & Dohme Corp. |
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates
|
|
JP7397000B2
(ja)
|
2018-04-30 |
2023-12-12 |
メルク・シャープ・アンド・ドーム・エルエルシー |
凍結乾燥変異ジフテリア毒素のジメチルスルホキシド中均一溶液を提供する方法
|
|
US12144855B2
(en)
|
2018-04-30 |
2024-11-19 |
Merck Sharp & Dohme Llc |
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
|
|
WO2020010016A1
(en)
|
2018-07-04 |
2020-01-09 |
Sutrovax, Inc. |
Self-adjuvanted immunogenic conjugates
|
|
WO2020010000A1
(en)
|
2018-07-04 |
2020-01-09 |
Sutrovax, Inc. |
Improved methods for the preparation of immunogenic conjugates
|
|
CN112543649B
(zh)
|
2018-07-04 |
2026-03-31 |
Vaxcyte公司 |
免疫原性缀合物的改进
|
|
US11260119B2
(en)
|
2018-08-24 |
2022-03-01 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
AU2019358622A1
(en)
|
2018-10-12 |
2021-06-17 |
Biological E Limited |
Multivalent pneumococcal polysaccharide-protein conjugate vaccine
|
|
CA3120922A1
(en)
|
2018-12-12 |
2020-06-18 |
Pfizer Inc. |
Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof
|
|
GEAP202415690A
(en)
|
2018-12-19 |
2024-01-10 |
Merck Sharp & Dohme Llc |
Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
|
CA3136278A1
(en)
|
2019-04-10 |
2020-10-15 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
|
|
BR112022001654A2
(pt)
|
2019-07-31 |
2022-07-12 |
Sanofi Pasteur Inc |
Composições conjugadas de proteinas de polissacarídeos pneumocócicos multivalentes e métodos de utilização dos mesmos
|
|
CA3159573A1
(en)
|
2019-11-01 |
2021-05-06 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
NZ790372A
(en)
|
2020-02-23 |
2026-01-30 |
Pfizer |
Escherichia coli compositions and methods thereof
|
|
WO2021229604A1
(en)
*
|
2020-05-14 |
2021-11-18 |
Serum Institute Of India Private Limited |
Methods for simultaneous fragmentation and purification of bacterial polysaccharides
|
|
WO2022035816A1
(en)
|
2020-08-10 |
2022-02-17 |
Inventprise, Llc |
Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f
|
|
KR20230056727A
(ko)
|
2020-08-26 |
2023-04-27 |
화이자 인코포레이티드 |
B군 스트렙토코쿠스 폴리사카라이드-단백질 접합체, 접합체를 생산하는 방법, 접합체를 포함하는 면역원성 조성물, 및 그의 용도
|
|
US12138302B2
(en)
|
2020-10-27 |
2024-11-12 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
MX2023004912A
(es)
|
2020-10-27 |
2023-05-16 |
Pfizer |
Composiciones de escherichia coli y metodos de las mismas.
|
|
KR20230097160A
(ko)
|
2020-11-04 |
2023-06-30 |
화이자 인코포레이티드 |
폐렴구균 백신에 사용하기 위한 면역원성 조성물
|
|
JP7804673B2
(ja)
|
2020-11-10 |
2026-01-22 |
ファイザー・インク |
コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用
|
|
US12357681B2
(en)
|
2020-12-23 |
2025-07-15 |
Pfizer Inc. |
E. coli FimH mutants and uses thereof
|
|
CA3218544A1
(en)
|
2021-05-03 |
2022-11-10 |
Pfizer Inc. |
Vaccination against bacterial and betacoronavirus infections
|
|
WO2022234416A1
(en)
|
2021-05-03 |
2022-11-10 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
|
MX2023013434A
(es)
|
2021-05-28 |
2023-12-12 |
Pfizer |
Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y sus usos.
|
|
EP4346893A2
(en)
|
2021-05-28 |
2024-04-10 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
CA3247998A1
(en)
|
2022-01-13 |
2023-07-20 |
Pfizer Inc. |
Immunogenic compositions based on conjugated capsular saccharidic antigens and their uses
|
|
CN119317445A
(zh)
|
2022-05-11 |
2025-01-14 |
辉瑞公司 |
用于生产含有防腐剂的疫苗制剂的方法
|
|
WO2024084397A1
(en)
|
2022-10-19 |
2024-04-25 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
|
WO2024110827A1
(en)
|
2022-11-21 |
2024-05-30 |
Pfizer Inc. |
Methods for preparing conjugated capsular saccharide antigens and uses thereof
|
|
JP2025537898A
(ja)
|
2022-11-22 |
2025-11-20 |
ファイザー・インク |
コンジュゲートさせた莢膜糖類抗原を含む免疫原性組成物およびその使用
|
|
IL321069A
(en)
|
2022-12-01 |
2025-07-01 |
Pfizer |
Pneumococcal conjugate vaccine preparations
|
|
EP4661911A1
(en)
|
2023-02-10 |
2025-12-17 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
KR20250163977A
(ko)
|
2023-03-30 |
2025-11-21 |
화이자 인코포레이티드 |
접합된 피막 사카라이드 항원을 포함하는 면역원성 조성물 및 그의 용도
|
|
WO2024211348A1
(en)
*
|
2023-04-06 |
2024-10-10 |
Vaxcyte, Inc. |
Purification of capsular polysaccharides
|
|
EP4694921A1
(en)
|
2023-04-14 |
2026-02-18 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
EP4701656A1
(en)
|
2023-04-24 |
2026-03-04 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
WO2024241172A2
(en)
|
2023-05-19 |
2024-11-28 |
Glaxosmithkline Biologicals Sa |
Methods for eliciting an immune response to respiratory syncycial virus and streptococcus pneumoniae infection
|
|
WO2025057078A1
(en)
|
2023-09-14 |
2025-03-20 |
Pfizer Inc. |
Adjuvanted immunogenic compositions comprising conjugated pneumococcal capsular saccharide antigens and uses thereof
|
|
WO2025133971A1
(en)
|
2023-12-23 |
2025-06-26 |
Pfizer Inc. |
Improved methods for producing bacterial capsular saccharide glycoconjugates
|
|
WO2025174398A1
(en)
|
2024-02-14 |
2025-08-21 |
Merck Sharp & Dohme Llc |
26-valent pneumococcal conjugate vaccines and methods of use thereof
|
|
WO2025186705A2
(en)
|
2024-03-06 |
2025-09-12 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
TW202602467A
(zh)
|
2024-03-11 |
2026-01-16 |
美商輝瑞股份有限公司 |
包含經共軛之大腸桿菌糖的免疫原性組成物及其用途
|
|
WO2025219904A1
(en)
|
2024-04-19 |
2025-10-23 |
Pfizer Inc. |
Improved methods for producing glycoconjugates by reductive amination in aprotic solvent
|